⌘K

Home/Filings/4/0001064901-24-000001

4//SEC Filing

KAY CHRISTINA 4

Accession 0001064901-24-000001

CIK 0001016504other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 12:41 PM ET

Size

5.5 KB

Accession

0001064901-24-000001

Insider Transaction Report

Form 4

Period: 2024-12-04

INTEGRATED BIOPHARMA INCINBP

DirectorExecutive Vice President

Transactions

Award
Stock Option (right to buy)
2024-12-04+125,000→ 125,000 total
Exercise: $0.34Exp: 2034-12-04→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1

filerCIK 0001064901

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 12:41 PM ET
Size: 5.5 KB

View on SEC.gov